Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute

Medical Oncology

Volumn 30, Issue 1, 2013, Pages

  Han, Boram ^a   Sun, Jong Mu ^a   Ahn, Jin Seok ^a   Park, Keunchil ^a   Ahn, Myung Ju ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Carcinoid tumor; Lung; Thymus

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CARCINOID; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LUNG TUMOR; MALE; MITOSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RARE DISEASE; THYMOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CARCINOID TUMOR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; THYMUS NEOPLASMS;

MLCS; MLOWN;

EID: 84880611506     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0479-x     Document Type: Article

References (29)

1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after "Carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063-72.
2. Öberg K, Jelic S, ESMO Guidelines Working Group. Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):220-2.
3. Rohtas KY, Shalini A, Richa A, Sunita S. Thymic atypical carcinoid. Indian J Chest Dis Allied Sci. 2009;51:181-4.
4. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529-53.
5. Tsuta K, Rasob MG, Kalhora N, Liuc DD, Wistubaa II, Morana CA. Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung. Lung Cancer. 2011;71:34-41.
6. Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS. Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radio Graph. 2006;26:41-58.
7. Yesner R. Small cell tumors of the lung. Am J Surg Pathol. 1983;7:775-85.
8. Hage R, de la Riviere AB, Seldenrijk CA, van den Bosch JM. Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol. 2003;10:697-704.
9. Fink G, Krelbaum T, Yellin A, Bendayan D, Saute M, Glazer M, et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest. 2001;119:1647-51.
10. Klemm KM, Moran CA. Primary neuroendocrine carcinomas of the thymus. Semin Diagn Pathol. 1999;16:32-41.
11. Garcia-Yuste M, Matilla J, Cueto A, Paniagua JM, Ramos G, Cañizares MA. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish multi-centric study of neuroendocrine tumours of the lung. Eur J Cardiothorac Surg. 2007;31:192-7.
12. Tiffet O, Nicholson A, Ladas G, Sheppard M, Goldstraw P. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest. 2003;124:140-7.
13. US Centers for Disease Control and Prevention. Health behaviors of adults: United States, 2005-2007. Vital Health Stat. 2010. Series 10, Number 245, Appendix II, p. 80.
14. International Union Against Cancer (UICC). TNM supplement: a commentary on uniform use. 3rd ed. New York: Wiley-Liss; 2003.
15. Vigg TA, Mantri S, Swarnalata G, Mulay K. Atypical carcinoid. Indian J Chest Dis Allied Sci. 2005;47:213-5.
16. Brandt VV, Heyman S, Marck EV, Hendriks J, Schil PV. Atypical presentation of an atypical carcinoid. Ann Thorac Surg. 2009;88:2004-6.
17. Terada T. Bronchial atypical carcinoid tumor without invasion but with marked intraluminal growth like branchial tree cast. Respir Med CME. 2010;3:179-82.
18. Moghe G, Jambhekar NA, Deshpande RK, Hejmadi R, Vyas J. Atypical carcinoid tumors of lung: clinicopathologic study of six cases. Asian Cardiovasc Thorac Ann. 2000;8:41-5.
19. Wen CC, Chen YC, Hsu YP, Sheu NH. Atypical carcinoid tumor of the thymus: a case report. Chin J Radiol. 2003;28:317-21.
20. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with classification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934-44.
21. Soga J, Yakuwa Y. Bronchopulmonary carcinoids: an analysis of 1,875 reported cases with special references to the comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg. 1999;5:211-9.
22. Olliaro A, Filosso PL, Donati G, Ruffini E. Atypical bronchial carcinoid: review of 46 patients. J Cardiovasc Surg. 2000;41:131-5.
23. Shimosato Y, Mukai K. Tumors of the thymus and related lesions. In: Shimosato Y, Mukai K, editors. Atlas of tumor pathology: tumors of the mediastinum, fasc 21, ser 3. Washington, DC: Armed Forces Institute of Pathology 1997;1:158-68.
24. Rosai J, Higa E, Davie J. Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis: a previously unrecognized association. Cancer. 1972;29:1075-83.
25. Thomas CF Jr, Tazelaar HD, Jett JR. Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest. 2001;119:1143-50.
26. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972;64:413-21.
27. Lung NCCN Clinical Practice Guidelines in Oncology. Small cell lung cancer. Version 2. 2012.
28. Thymus NCCN Clinical Practice Guidelines in Oncology Neuroendocrine tumors. Version 1. 2012.
29. Caplin M, Buscombe J, Hilson A, Jones A, Watkinson A, Burroughs A. Carcinoid tumor. Lancet. 1998;352:799-804.